IN THIS ISSUE

John Carroll
Tougher standards being applied by insurers spur debate about what constitutes true value in a new drug
Marcia Naveh, MD
By assisting doctors, insurers can get all the payment that they are due, but that too often is lost
Peer-Reviewed
Mary V. Mason, MD, MBA
Kara M. House, MBA
Janice Linehan, PA-C, MHP
Viewpoint
Michael L. Millenson
As an idea, Geisinger’s ProvenCare program is a winner. What happens in the marketplace remains to be seen.
Medication Management
Martin Sipkoff
Although federal health agencies support the idea of having pharmacists administer vaccines to their patients, the roadblock continues to be a question of payment
Tomorrow's Medicine
Thomas Morrow, MD
Heart valves made from new composite materials minimize calcification, a common problem that can lead to a second valve replacement
News and Commentary
News and Commentary